Bacterial News and Research

RSS

Researchers reveal how pneumonia-causing bacteria obtain essential nutrient from our bodies

Australian researchers have revealed how the bacterium Streptococcus pneumoniae (pneumococcus) obtains the essential nutrient, manganese, from our bodies, which could lead to better therapies to target what is a life-threatening, antibiotic-resistant pathogen.

6 Aug 2021

Science academies offer recommendations to improve pandemic preparedness in the future

In the run-up to the summit of the G20 states on October 30 and 31, 2021, in Rome/Italy, the science academies of these countries (Science20 Dialogue), including the German National Academy of Sciences Leopoldina, have published the joint statement "Pandemic preparedness and the role of science".

6 Aug 2021

New DNA writing technique can precisely and efficiently edit bacterial genomes

Biological engineers at MIT have devised a new way to efficiently edit bacterial genomes and program memories into bacterial cells by rewriting their DNA.

5 Aug 2021

Bacteriophages named after Norfolk village of Colney could help combat C. difficile infections

Viruses have a menacing reputation for causing disease but some that target bacteria could actually benefit human health.

5 Aug 2021

Drug-eluting endotracheal tubes for preventing airway complications

In a proof-of-concept study, researchers at Children's Hospital of Philadelphia have created a coating that can be applied to endotracheal tubes and release antimicrobial peptides that target infectious bacteria with specificity.

4 Aug 2021

Reducing antibiotic prescribing in primary care alone may not stop drug-resistant E. coli infections

Strategies to reduce antibiotic prescribing in primary care are insufficient alone to halt the rise in drug resistant E. coli infections in England, a new report concludes.

4 Aug 2021

Next-Generation Sequencing and the Diagnosis of Disease

In this interview, Professor John Rossen talks about next-generation sequencing and it's implications for the diagnosis of disease.

From Tecan 4 Aug 2021

CHOP researchers identify two proteins that could be used for a potential NTHi vaccine

Scientists at Children's Hospital of Philadelphia have identified two proteins that could be used for a potential vaccine against nontypeable Haemophilus influenzae (NTHi).

2 Aug 2021

Study paves the way to a new drug design concept

Hydrogen peroxide reacts with copper to produce hydroxyl radicals with strong antibacterial properties. However, this requires high copper concentrations because two copper atoms have to come close together, which occurs by chance.

31 Jul 2021

New collaboration aims to boost vaccines manufacturing capability in South Africa

The Medicines Patent Pool and the World Health Organization, Afrigen Biologics Limited, the Biologicals and Vaccines Institute of Southern Africa, the South African Medical Research Council and Africa Centres for Disease Control and Prevention have signed a letter of intent to address the global imbalance of manufacturing capacity for COVID-19 vaccines.

30 Jul 2021

Researchers develop two complementary bladder models to study UTIs

Urinary tract infections (UTIs) are among the most common bacterial infections. They usually require treatment with antibiotics, and almost a quarter of treated cases lead to recurrent infection.

30 Jul 2021

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Scientists from the UK and US have recently investigated immunological consequences of secondary Streptococcus pneumoniae (S. pneumoniae) infection in coronavirus disease 2019 (COVID-19) patients.

29 Jul 2021

Mini-antibodies efficiently block SARS-CoV-2 virus

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants.

28 Jul 2021

Antibacterial immunity may change in the intestines based on circadian cycle

The body's ability to prevent food poisoning by producing a natural antimicrobial compound increases during the day, when exposure to noxious bacteria is most likely, a new study by UT Southwestern scientists suggests.

28 Jul 2021

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Scientists from the UK have recently identified an antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine as a potential serum biomarker to diagnose active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server while awaiting peer review.

27 Jul 2021

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

A research team led by Dr Aixin YAN, Associate Professor from the Research Division for Molecular & Cell Biology, Faculty of Science, in collaboration with Honorary Clinical Professor Patrick CY WOO from the Department of Microbiology, Li Ka Shing Faculty of Medicine, the University of Hong Kong, reported the development of a transferrable and integrative type I CRISPR-based platform.

23 Jul 2021

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

A new method that analyzes how individual immune cells react to the bacteria that cause tuberculosis could pave the way for new vaccine strategies against this deadly disease, and provide insights into fighting other infectious diseases around the world.

22 Jul 2021

'Good cholesterol' protects the liver from inflammation and injury, study shows

The body's so-called good cholesterol may be even better than we realize. New research from Washington University School of Medicine in St. Louis suggests that one type of high-density lipoprotein (HDL) has a previously unknown role in protecting the liver from injury.

22 Jul 2021

Antibiotics may be the new weapon to fight against melanoma

Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumours in mice. Their findings were published in the Journal of Experimental Medicine.

22 Jul 2021

Research provides new insight into uncontrolled inflammation in COVID-19 patients

Research led by Queen Mary University of London provides new insight into the mechanisms that lead to uncontrolled inflammation in COVID-19 patients.

22 Jul 2021

Bacterial News and Research

Researchers reveal how pneumonia-causing bacteria obtain essential nutrient from our bodies

Science academies offer recommendations to improve pandemic preparedness in the future

New DNA writing technique can precisely and efficiently edit bacterial genomes

Bacteriophages named after Norfolk village of Colney could help combat C. difficile infections

Drug-eluting endotracheal tubes for preventing airway complications

Reducing antibiotic prescribing in primary care alone may not stop drug-resistant E. coli infections

Next-Generation Sequencing and the Diagnosis of Disease

CHOP researchers identify two proteins that could be used for a potential NTHi vaccine

Study paves the way to a new drug design concept

New collaboration aims to boost vaccines manufacturing capability in South Africa

Researchers develop two complementary bladder models to study UTIs

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Mini-antibodies efficiently block SARS-CoV-2 virus

Antibacterial immunity may change in the intestines based on circadian cycle

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

'Good cholesterol' protects the liver from inflammation and injury, study shows

Antibiotics may be the new weapon to fight against melanoma

Research provides new insight into uncontrolled inflammation in COVID-19 patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News